Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free ABOS Stock Alerts

Acumen Pharmaceuticals (ABOS) Institutional Ownership

Acumen Pharmaceuticals logo
$2.54 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$2.54 +0.00 (+0.20%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Acumen Pharmaceuticals (NASDAQ:ABOS)

Current
Institutional Ownership
Percentage
71.01%
Number of
Institutional Buyers
(last 12 months)
23
Total
Institutional Inflows
(last 12 months)
$6.87M
Number of
Institutional Sellers
(last 12 months)
16
Total
Institutional Outflows
(last 12 months)
$5.62M
Get ABOS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acumen Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ABOS Institutional Buying and Selling by Quarter

Acumen Pharmaceuticals Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE320,216$756K0.0%+33.3%0.443%
5/18/2026 ADAR1 Capital Management LLC2,156,334$5.09M0.3%+142.0%2.985%
5/15/2026 Rangeley Capital LLC35,000$83K0.1%N/A0.048%
5/15/2026 OMERS ADMINISTRATION Corp28,600$67K0.0%+27.4%0.040%
5/14/2026 Renaissance Technologies LLC473,946$1.12M0.0%+12.0%0.656%
5/14/2026 Sei Investments Co.11,564$27K0.0%N/A0.016%
5/7/2026 Dimensional Fund Advisors LP119,756$282K0.0%+144.1%0.166%
4/27/2026 PFG Investments LLC80,850$191K0.0%+325.5%0.112%
4/16/2026 SG Americas Securities LLC719,257$1.70M0.0%+79.3%0.996%
2/18/2026 XTX Topco Ltd49,563$105K0.0%N/A0.082%
2/18/2026 Ikarian Capital LLC254,312$537K0.0%-4.3%0.420%
2/18/2026 Quadrature Capital Ltd49,046$103K0.0%N/A0.081%
2/18/2026 Millennium Management LLC584,143$1.23M0.0%-2.9%0.964%
2/18/2026 Boothbay Fund Management LLC39,585$84K0.0%-22.4%0.065%
2/18/2026 Bridgeway Capital Management LLC170,171$359K0.0%-10.5%0.281%
2/16/2026 OMERS ADMINISTRATION Corp22,454$47K0.0%N/A0.037%
2/13/2026 Marshall Wace LLP20,907$44K0.0%N/A0.035%
2/13/2026 State Street Corp100,178$211K0.0%-6.1%0.165%
2/12/2026 Jane Street Group LLC142,123$300K0.0%-31.4%0.235%
2/12/2026 Renaissance Technologies LLC423,100$893K0.0%-27.6%0.699%
2/12/2026 Dimensional Fund Advisors LP49,062$104K0.0%+12.7%0.081%
2/10/2026 Goldman Sachs Group Inc.117,851$249K0.0%-19.9%0.195%
2/9/2026 Geode Capital Management LLC410,206$866K0.0%+2.9%0.677%
2/9/2026 Prospera Financial Services Inc50,000$106K0.0%N/A0.083%
2/4/2026 Independent Advisor Alliance19,000$40K0.0%N/A0.031%
1/26/2026 PFG Investments LLC19,000$40K0.0%+65.2%0.031%
12/15/2025 Hudson Bay Capital Management LP725,004$1.24M0.0%-12.1%1.197%
11/17/2025 Jacobs Levy Equity Management Inc.16,001$27K0.0%N/A0.026%
11/17/2025 Susquehanna International Group LLP214,440$367K0.0%+26.5%0.354%
11/17/2025 Qube Research & Technologies Ltd32,881$56K0.0%-42.9%0.054%
11/17/2025 Millennium Management LLC601,716$1.03M0.0%-69.1%0.993%
11/17/2025 Bank of America Corp DE213,729$365K0.0%+45.4%0.353%
11/14/2025 ADAR1 Capital Management LLC891,183$1.52M0.1%-2.7%1.471%
11/14/2025 Bridgeway Capital Management LLC190,171$325K0.0%+65.1%0.314%
11/13/2025 Pathstone Holdings LLC859,110$1.47M0.0%-18.8%1.418%
11/13/2025 Franklin Resources Inc.2,305,096$3.94M0.0%-25.1%3.806%
11/7/2025Vanguard Group Inc.1,651,472$2.82M0.0%-2.2%2.727%
10/23/2025 SG Americas Securities LLC403,878$691K0.0%N/A0.667%
8/19/2025 Marex Group plc33,300$39K0.0%N/A0.055%
8/18/2025 Hudson Bay Capital Management LP825,004$957K0.0%+7.1%1.362%
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
8/15/2025 Hudson Bay Capital Management LP825,004$957K0.0%+7.1%1.362%
8/15/2025 Bank of America Corp DE147,009$171K0.0%-7.5%0.243%
8/14/2025 Jane Street Group LLC175,670$204K0.0%+1,526.0%0.290%
8/14/2025 Qube Research & Technologies Ltd57,559$67K0.0%+160.0%0.095%
8/13/2025 Marshall Wace LLP137,943$160K0.0%N/A0.228%
8/12/2025 Franklin Resources Inc.3,077,039$3.57M0.0%-2.1%5.080%
8/8/2025 Geode Capital Management LLC396,626$460K0.0%-54.0%0.655%
8/1/2025 Y Intercept Hong Kong Ltd250,848$291K0.0%N/A0.414%
6/27/2025 Goldman Sachs Group Inc.196,207$216K0.0%-10.5%0.324%
5/16/2025Goldman Sachs Group Inc.196,207$216K0.0%-10.5%0.324%
5/16/2025AQR Capital Management LLC41,735$46K0.0%N/A0.069%
5/16/2025ADAR1 Capital Management LLC146,183$161K0.0%+55.0%0.241%
5/12/2025Nuveen LLC78,446$86K0.0%N/A0.130%
5/12/2025Invesco Ltd.127,798$141K0.0%+544.1%0.211%
2/17/2025Two Sigma Investments LP301,268$518K0.0%-2.7%0.501%
2/17/2025Two Sigma Advisers LP499,100$858K0.0%+6.4%0.831%
2/17/2025Millennium Management LLC1,344,745$2.31M0.0%-26.7%2.238%
2/17/2025Deutsche Bank AG96,995$167K0.0%+468.7%0.161%
2/17/2025Bank of America Corp DE148,668$256K0.0%+7.2%0.247%
2/14/2025Jane Street Group LLC30,740$53K0.0%-116.1%0.051%
2/14/2025Susquehanna Fundamental Investments LLC14,731$25K0.0%N/A0.025%
2/14/2025Rock Springs Capital Management LP1,838,916$3.16M0.1%-20.0%3.061%
2/14/2025Tower Research Capital LLC TRC20,624$35K0.0%+427.5%0.034%
2/14/2025Dimensional Fund Advisors LP98,016$169K0.0%+73.3%0.163%
2/13/2025Barclays PLC93,082$161K0.0%+50.1%0.155%
2/13/2025Renaissance Technologies LLC257,213$442K0.0%-16.0%0.428%
2/13/2025ADAR1 Capital Management LLC94,294$162K0.0%N/A0.157%
2/12/2025Franklin Resources Inc.3,273,633$5.63M0.0%-7.8%5.449%
2/12/2025JPMorgan Chase & Co.937,908$1.61M0.0%+1,387.2%1.561%
2/11/2025Clune & Associates LTD.16,500$28K0.0%N/A0.027%
2/11/2025Intech Investment Management LLC18,847$32K0.0%N/A0.031%
2/6/2025Charles Schwab Investment Management Inc.126,747$218K0.0%+16.6%0.211%
1/30/2025Rhumbline Advisers53,076$91K0.0%-40.0%0.088%
1/17/2025SG Americas Securities LLC25,631$44K0.0%+44.2%0.043%
12/26/2024JPMorgan Chase & Co.63,066$156K0.0%+252.8%0.105%
11/27/2024Franklin Resources Inc.3,549,069$8.34M0.0%+5.4%5.907%
11/19/2024Barclays PLC61,997$154K0.0%+189.1%0.103%
11/16/2024Geode Capital Management LLC864,528$2.14M0.0%+6.5%1.439%
11/15/2024Barclays PLC61,997$154K0.0%+189.1%0.103%
11/15/2024State Street Corp516,406$1.28M0.0%+18.3%0.860%
11/13/2024FMR LLC2,028,117$5.03M0.0%+0.3%3.376%
11/13/2024The Manufacturers Life Insurance Company52,333$130K0.0%-12.8%0.087%
10/3/2024SG Americas Securities LLC17,772$44K0.0%N/A0.030%
8/16/2024Murchinson Ltd.56,250$136K0.0%N/A0.094%
8/15/2024Millennium Management LLC1,954,085$4.73M0.0%-25.7%3.252%
8/14/2024Murchinson Ltd.56,250$136K0.0%N/A0.094%
8/12/2024Marathon Trading Investment Management LLC26,298$64K0.0%-56.2%0.044%
8/9/2024Renaissance Technologies LLC338,100$818K0.0%N/A0.563%
8/9/2024Dimensional Fund Advisors LP56,548$137K0.0%-8.4%0.094%
8/8/2024American Century Companies Inc.45,444$110K0.0%+31.3%0.076%
Read this warning immediately (Ad)

Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Read Porter Stansberry's full breakdown and protect your wealth now
8/1/2024Rhumbline Advisers52,323$127K0.0%N/A0.087%
7/26/2024Bank of New York Mellon Corp126,422$306K0.0%N/A0.210%
7/19/2024Gladius Capital Management LP10,939$26K0.0%N/A0.018%
5/17/2024Ikarian Capital LLC266,435$1.08M0.1%-15.5%0.443%
5/15/2024Price T Rowe Associates Inc. MD1,098,276$4.45M0.0%N/A1.828%
5/10/2024Vanguard Group Inc.1,665,058$6.74M0.0%-9.5%2.771%
5/7/2024Susquehanna Fundamental Investments LLC62,518$253K0.0%N/A0.104%
5/7/2024SG Americas Securities LLC12,856$52K0.0%N/A0.021%
2/23/2024Chicago Partners Investment Group LLC18,315$70K0.0%+34.9%0.032%
2/15/2024Parkman Healthcare Partners LLC603,497$2.32M0.3%+20.7%1.042%


ABOS Institutional Ownership - Frequently Asked Questions

During the previous two years, 53 institutional investors and hedge funds held shares of Acumen Pharmaceuticals. The most heavily invested institutionals were ADAR1 Capital Management LLC ($5.09M), FMR LLC ($5.03M), Franklin Resources Inc. ($3.94M), Rock Springs Capital Management LP ($3.16M), Vanguard Group Inc. ($2.82M), SG Americas Securities LLC ($1.70M), and JPMorgan Chase & Co. ($1.61M).Learn more on Acumen Pharmaceuticals' institutional investors.

71.01% of Acumen Pharmaceuticals' stock is owned by institutional investors. Learn more on ABOS's institutional investor holdings.

Of the 43 institutional investors that purchased Acumen Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: ADAR1 Capital Management LLC ($1.41M), JPMorgan Chase & Co. ($920.03K), SG Americas Securities LLC ($747.72K), Renaissance Technologies LLC ($388.95K), Jane Street Group LLC ($386.01K), Y Intercept Hong Kong Ltd ($250.85K), and Franklin Resources Inc. ($181.45K).

Institutional investors have bought a total of 3,473,851 shares in the last 24 months. This purchase volume represents approximately $6.87M in transactions.

Of the 16 institutional investors that sold Acumen Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($1.37M), Franklin Resources Inc. ($836.84K), Geode Capital Management LLC ($465.27K), Pathstone Holdings LLC ($199.42K), Renaissance Technologies LLC ($161.19K), Hudson Bay Capital Management LP ($100K), and Jane Street Group LLC ($65.12K).

Institutional investors have sold a total of 3,394,952 shares in the last 24 months. This volume of shares sold represents approximately $5.62M in transactions.


Related Companies

This page (NASDAQ:ABOS) was last updated on 5/28/2026 by MarketBeat.com Staff.
From Our Partners
This Tech Could Be Bigger Than Apple, Amazon, and Microsoft Combined
A breakthrough technology backed by Elon Musk, Sam Altman, and Nvidia CEO Jensen Huang may hold the answer to ...
Altimetry | Sponsoredtc pixel
The "hidden" half of the SpaceX IPO
Most investors are focused on the SpaceX IPO - but the bigger opportunity may lie elsewhere. On Feb. 2, Elon M...
Weiss Ratings | Sponsoredtc pixel
I paid $5,000 to hear Elon say this
One investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...
InvestorPlace | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump’s New Dollar revealed
The last time something like this happened was 1974 - a secret deal that quietly determined the financial fate...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
A 25,000% opportunity
Angel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...
The Oxford Club | Sponsoredtc pixel
How daily 'stock bets' hit 87% of the time
A daily trading system claims an 87% win rate on short-term stock plays - and it runs just one hour a day, fro...
Trade To Close | Sponsoredtc pixel